Sanofi (SNYNF) stock
SNYNFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as SNY
$78.48−0.07 (-0.09%)
Close on Oct 19, 2026Market cap $191.40BP/E 22.1Yield –
Sanofi r&d expenses
Research and development expenses are spending on new products and technology.
For fiscal 2025 it was €7.84B, up 6.1% from the year before. Over ten years it grew 4.4% a year on average. The highest annual figure on record is €7.84B in fiscal 2025.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | €7.84B | +6.1% |
| FY2024 | Dec 31, 2024 | €7.39B | +13.6% |
| FY2023 | Dec 31, 2023 | €6.51B | +0.1% |
| FY2022 | Dec 31, 2022 | €6.50B | +14.2% |
| FY2021 | Dec 31, 2021 | €5.69B | +2.9% |
| FY2020 | Dec 31, 2020 | €5.53B | -8.1% |
| FY2019 | Dec 31, 2019 | €6.02B | +2.1% |
| FY2018 | Dec 31, 2018 | €5.89B | +7.7% |
| FY2017 | Dec 31, 2017 | €5.47B | +5.8% |
| FY2016 | Dec 31, 2016 | €5.17B | +1.8% |
| FY2015 | Dec 31, 2015 | €5.08B | – |
See a number that looks wrong?